| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |